Clearside Biomedical President and Chief Executive Office George Lasezkay's 2021 pay jumps 71% to $2.3M

Clearside Biomedical reports 2021 executive compensation

By ExecPay News

Published: April 29, 2022

Clearside Biomedical reported fiscal year 2021 executive compensation information on April 29, 2022.
In 2021, three executives at Clearside Biomedical received on average a compensation package of $1.9M, a 113% increase compared to previous year.
Average pay of disclosed executives at Clearside Biomedical
George Lasezkay, President and Chief Executive Office, received $2.3M in total, which increased by 71% compared to 2020. 40% of Lasezkay's compensation, or $943K, was in option awards. Lasezkay also received $36K in bonus, $268K in non-equity incentive plan, $516K in salary, $562K in stock awards, as well as $16K in other compensation.
Thomas Ciulla, Chief Medical Officer, received a compensation package of $1.8M, which increased by 172% compared to previous year. 45% of the compensation package, or $822K, was in option awards.
Charles A. Deignan, Chief Financial Officer, earned $1.5M in 2021, a 141% increase compared to previous year.

Related executives

George Lasezkay

Clearside Biomedical

Chief Executive Officer

Charles Deignan

Clearside Biomedical

Chief Financial Officer

Thomas Ciulla

Clearside Biomedical

Chief Medical Officer

You may also like

Source: SEC filing on April 29, 2022.